Asedebart, an experimental treatment designed to ease symptoms in Cushing’s disease and other forms of endogenous Cushing’s syndrome, has been granted orphan drug status in the European Union. That designation, awarded to the Lundbeck therapy by the European Commission, aims to incentivize the development of treatments for rare…
Discussion
I smile the entire night, have a few sips of wine, and push myself. A long walk? You bet. A staircase? I can handle it. You want to eat at 9 p.m. and then go home in the dark? Sure. I try my best to appear normal. It’s not that…
Discussion
People with Cushing’s syndrome may continue to have excess abdominal fat and diabetes years after achieving disease remission, putting them at an increased risk of experiencing cardiovascular, or heart-related, problems, a new study from Europe found. The data showed that, seven years after remission, individuals who’d had Cushing’s were more…
Becoming educated and informed about Cushing’s disease is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Cushing’s journey.
Besides surgery, there are several therapeutic strategies that may be used to manage Cushing’s disease. Here you can find more information about some of the approved and experimental treatments.
Get regular updates to your inbox.
